食管癌诊疗规范(2018年版)

2018-12-13 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

我国食管癌发病虽有明显的地区差异,但食管癌的病死率均较高。对高危人群和高发地区人群的筛查,早期发现和早期治疗阻断早期食管癌发展成为中晚期食管癌是提高食管癌生存效果和保证患者生活质量的根本出路。也是减轻我国政府和民众医疗负担的长期有效措施。另外,对于中晚期食管癌的规范诊断和治疗也是改善中晚期食管癌效果的有效措施,可使众多的食管癌患者受益,因此,食管癌筛查、早诊早治和规范化诊治是全国各级各类具备基本资

中文标题:

食管癌诊疗规范(2018年版)

发布日期:

2018-12-13

简要介绍:

我国食管癌发病虽有明显的地区差异,但食管癌的病死率均较高。对高危人群和高发地区人群的筛查,早期发现和早期治疗阻断早期食管癌发展成为中晚期食管癌是提高食管癌生存效果和保证患者生活质量的根本出路。也是减轻我国政府和民众医疗负担的长期有效措施。另外,对于中晚期食管癌的规范诊断和治疗也是改善中晚期食管癌效果的有效措施,可使众多的食管癌患者受益,因此,食管癌筛查、早诊早治和规范化诊治是全国各级各类具备基本资质医疗机构及其医务人员的重要任务。 

拓展指南:食管癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=食管癌诊疗规范(2018年版))] GetToolGuiderByIdResponse(projectId=1, id=30c721c001681670, title=食管癌诊疗规范(2018年版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=我国食管癌发病虽有明显的地区差异,但食管癌的病死率均较高。对高危人群和高发地区人群的筛查,早期发现和早期治疗阻断早期食管癌发展成为中晚期食管癌是提高食管癌生存效果和保证患者生活质量的根本出路。也是减轻我国政府和民众医疗负担的长期有效措施。另外,对于中晚期食管癌的规范诊断和治疗也是改善中晚期食管癌效果的有效措施,可使众多的食管癌患者受益,因此,食管癌筛查、早诊早治和规范化诊治是全国各级各类具备基本资, cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 13 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>我国食管癌发病虽有明显的地区差异,但食管癌的病死率均较高。对高危人群和高发地区人群的筛查,早期发现和早期治疗阻断早期食管癌发展成为中晚期食管癌是提高食管癌生存效果和保证患者生活质量的根本出路。也是减轻我国政府和民众医疗负担的长期有效措施。另外,对于中晚期食管癌的规范诊断和治疗也是改善中晚期食管癌效果的有效措施,可使众多的食管癌患者受益,因此,食管癌筛查、早诊早治和规范化诊治是全国各级各类具备基本资质医疗机构及其医务人员的重要任务。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>食管癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=c0ac01c00166e150" title="2018 中国专家共识:食管癌放疗患者肠内营养-英文版" target=_blank>2018 中国专家共识:食管癌放疗患者肠内营养-英文版</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=40d101c00160031e" title="2018 台湾共识声明:食管癌的营养治疗" target=_blank>2018 台湾共识声明:食管癌的营养治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c8aa1c0015235e6" title="食管癌根治术胸部淋巴结清扫中国专家共识(2017版)" target=_blank>食管癌根治术胸部淋巴结清扫中国专家共识(2017版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=199401c001a66298" title="2017年UICC/AJCC 第8版肺癌/食管癌TNM分期标准" target=_blank>2017年UICC/AJCC 第8版肺癌/食管癌TNM分期标准</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=857ac1c001288284" title="2016 ESMO临床实践指南:食管癌的诊断,治疗及随访" target=_blank>2016 ESMO临床实践指南:食管癌的诊断,治疗及随访</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%A3%9F%E7%AE%A1%E7%99%8C" target=_blank>有关食管癌更多指南</a></ul>, tagList=[TagDto(tagId=84928, tagName=食管癌诊疗规范)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11443, appHits=1303, showAppHits=12, pcHits=8369, showPcHits=3004, likes=243, shares=49, comments=7, approvalStatus=1, publishedTime=Sat Dec 29 22:32:23 CST 2018, publishedTimeString=2018-12-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 29 22:32:23 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:43:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=食管癌诊疗规范(2018年版))])
食管癌诊疗规范(2018年版)
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1227902, encodeId=09e6122e90287, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3828203358, createdName=ms7000001624019503, createdTime=Wed Jun 22 08:11:47 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080047, encodeId=1a49108004e3a, content=i学习lle了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Tue Dec 14 19:53:58 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975249, encodeId=34d89e5249cd, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9b41515342, createdName=kcy_city, createdTime=Sun Jun 20 22:18:08 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962117, encodeId=010096211e44, content=与2011年的指南有何不同? , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2695490714, createdName=撤了你的职, createdTime=Sat May 01 12:45:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946528, encodeId=842094652819, content=真的很实用对临床帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOK08AQHJbylpsuNYNlWRgZocTYNyVGEJ6oXa4e41iahRONTxTUiaX6sMyrVC2NYNRMxuzU9XBPIgg/132, createdBy=d3262549016, createdName=TLM, createdTime=Mon Mar 08 20:02:03 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2022-06-22 ms7000001624019503

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1227902, encodeId=09e6122e90287, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3828203358, createdName=ms7000001624019503, createdTime=Wed Jun 22 08:11:47 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080047, encodeId=1a49108004e3a, content=i学习lle了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Tue Dec 14 19:53:58 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975249, encodeId=34d89e5249cd, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9b41515342, createdName=kcy_city, createdTime=Sun Jun 20 22:18:08 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962117, encodeId=010096211e44, content=与2011年的指南有何不同? , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2695490714, createdName=撤了你的职, createdTime=Sat May 01 12:45:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946528, encodeId=842094652819, content=真的很实用对临床帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOK08AQHJbylpsuNYNlWRgZocTYNyVGEJ6oXa4e41iahRONTxTUiaX6sMyrVC2NYNRMxuzU9XBPIgg/132, createdBy=d3262549016, createdName=TLM, createdTime=Mon Mar 08 20:02:03 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-12-14 ms9000001410187120

    i学习lle了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1227902, encodeId=09e6122e90287, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3828203358, createdName=ms7000001624019503, createdTime=Wed Jun 22 08:11:47 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080047, encodeId=1a49108004e3a, content=i学习lle了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Tue Dec 14 19:53:58 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975249, encodeId=34d89e5249cd, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9b41515342, createdName=kcy_city, createdTime=Sun Jun 20 22:18:08 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962117, encodeId=010096211e44, content=与2011年的指南有何不同? , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2695490714, createdName=撤了你的职, createdTime=Sat May 01 12:45:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946528, encodeId=842094652819, content=真的很实用对临床帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOK08AQHJbylpsuNYNlWRgZocTYNyVGEJ6oXa4e41iahRONTxTUiaX6sMyrVC2NYNRMxuzU9XBPIgg/132, createdBy=d3262549016, createdName=TLM, createdTime=Mon Mar 08 20:02:03 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-06-20 kcy_city

    学习了!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1227902, encodeId=09e6122e90287, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3828203358, createdName=ms7000001624019503, createdTime=Wed Jun 22 08:11:47 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080047, encodeId=1a49108004e3a, content=i学习lle了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Tue Dec 14 19:53:58 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975249, encodeId=34d89e5249cd, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9b41515342, createdName=kcy_city, createdTime=Sun Jun 20 22:18:08 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962117, encodeId=010096211e44, content=与2011年的指南有何不同? , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2695490714, createdName=撤了你的职, createdTime=Sat May 01 12:45:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946528, encodeId=842094652819, content=真的很实用对临床帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOK08AQHJbylpsuNYNlWRgZocTYNyVGEJ6oXa4e41iahRONTxTUiaX6sMyrVC2NYNRMxuzU9XBPIgg/132, createdBy=d3262549016, createdName=TLM, createdTime=Mon Mar 08 20:02:03 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-05-01 撤了你的职

    与2011年的指南有何不同?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1227902, encodeId=09e6122e90287, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3828203358, createdName=ms7000001624019503, createdTime=Wed Jun 22 08:11:47 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080047, encodeId=1a49108004e3a, content=i学习lle了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Tue Dec 14 19:53:58 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975249, encodeId=34d89e5249cd, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9b41515342, createdName=kcy_city, createdTime=Sun Jun 20 22:18:08 CST 2021, time=2021-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962117, encodeId=010096211e44, content=与2011年的指南有何不同? , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2695490714, createdName=撤了你的职, createdTime=Sat May 01 12:45:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946528, encodeId=842094652819, content=真的很实用对临床帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOK08AQHJbylpsuNYNlWRgZocTYNyVGEJ6oXa4e41iahRONTxTUiaX6sMyrVC2NYNRMxuzU9XBPIgg/132, createdBy=d3262549016, createdName=TLM, createdTime=Mon Mar 08 20:02:03 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-03-08 TLM

    真的很实用对临床帮助很大

    0